title: [Complications of arterial infusion of CDDP in the treatment of malignant neoplasms].
abstract: Arterial infusion of cis-diamminedichloroplatinum (CDDP) is an effective therapy for malignant neoplasms. Severe complications after this therapy in 298 patients with malignant tumors were reviewed in our institute from March 1982 to August 1989. Arteries infused with CDDP and the number of infusions were as follows: bronchial artery (a.) 277, hepatic a. 153, internal iliac a. 51, femoral or popliteal a. 15, lumbar a. 6, pulmonary a. 5, esophageal a. 3 and intercostal a. 3. Eight cases of severe complications were encountered: 3 of esophageal ulcer, 3 of spinal paralysis, and one each of mediastinitis and toe necrosis. The arteries responsible for complications were the bronchial a. in 3 cases of esophageal ulcer and 2 of spinal paralysis, intercostal a. in one of spinal paralysis, esophageal a. in one of mediastinitis and popliteal a. in toe necrosis. Complication rates were 2.7% (8/298 cases) and 1.5% (8/518 infusions). Angiotensin II was infused in 6 of 8 of the cases with complications. The complication rate was 2.9% (6/209 infusions) in the group with CDDP and angiotensin II and 0.6% (2/309 infusions) in the group with CDDP only. Arterial infusion of CDDP, especially combined with angiotensin II, should be done in consideration of the arteries responsible for such complications.
authors.affiliation: Department of Radiology, Faculty of Medicine, Kagoshima University.
authors.forename: F
authors.initials: F
authors.lastname: Fujiyoshi
authors.forename: H
authors.initials: H
authors.lastname: Inoue
authors.forename: K
authors.initials: K
authors.lastname: Ikeda
authors.forename: A
authors.initials: A
authors.lastname: Hori
authors.forename: M
authors.initials: M
authors.lastname: Satake
authors.forename: I
authors.initials: I
authors.lastname: Eiro
authors.forename: N
authors.initials: N
authors.lastname: Miyazono
authors.forename: T
authors.initials: T
authors.lastname: Yano
authors.forename: S
authors.initials: S
authors.lastname: Onohara
authors.forename: N
authors.initials: N
authors.lastname: Uchiyama
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy*; D000293:Adolescent; D000328:Adult; D000368:Aged; D000804:Angiotensin II / Q000008:administration & dosage; D001981:Bronchial Arteries; D002945:Cisplatin / Q000009:adverse effects*; D004935:Esophageal Diseases / Q000139:chemically induced*; D004938:Esophageal Neoplasms / Q000188:drug therapy; D005260:Female; D006801:Humans; D007261:Infusions, Intra-Arterial / Q000009:adverse effects*; D008175:Lung Neoplasms / Q000188:drug therapy*; D008297:Male; D008480:Mediastinitis / Q000139:chemically induced; D008875:Middle Aged; D009336:Necrosis; D010243:Paralysis / Q000139:chemically induced*; D014034:Toes / Q000473:pathology; D014456:Ulcer / Q000139:chemically induced
chemical_list: D000804:Angiotensin II; D002945:Cisplatin